Albert Herz

Albert Herz's AcademicInfluence.com Rankings

Albert Herz

Biology

#3341

World Rank

#5125

Historical Rank

Neuroscience

#314

World Rank

#330

Historical Rank

biology Degrees

Download Badge

Biology

Albert Herz's Degrees

Doctorate Psychiatry Stanford University

Why Is Albert Herz Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Albert Herz's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Psychotomimesis mediated by kappa opiate receptors (1986) (802)
Endogenous opioid systems and alcohol addiction (1997) (761)
Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway. (1992) (586)
Opioids from immunocytes interact with receptors on sensory nerves to inhibit nociception in inflammation. (1990) (560)
Analgesic effect of intraarticular morphine after arthroscopic knee surgery. (1991) (553)
The Effects of Opioid Peptides on Dopamine Release in the Nucleus Accumbens: An In Vivo Microdialysis Study (1990) (543)
Peripheral opioid receptors mediating antinociception in inflammation. Evidence for involvement of mu, delta and kappa receptors. (1989) (534)
Antagonists with negative intrinsic activity at delta opioid receptors coupled to GTP-binding proteins. (1989) (516)
Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway (1992) (478)
Neuroanatomical sites mediating the motivational effects of opioids as mapped by the conditioned place preference paradigm in rats. (1993) (455)
Inflammation of the rat paw enhances axonal transport of opioid receptors in the sciatic nerve and increases their density in the inflamed tissue (1993) (350)
Unilateral inflammation of the hindpaw in rats as a model of prolonged noxious stimulation: Alterations in behavior and nociceptive thresholds (1988) (344)
Motivational properties of kappa and mu opioid receptor agonists studied with place and taste preference conditioning (2004) (304)
Gene expression and localization of opioid peptides in immune cells of inflamed tissue: Functional role in antinociception (1992) (284)
Examination of the neurochemical substrates mediating the motivational effects of opioids: role of the mesolimbic dopamine system and D-1 vs. D-2 dopamine receptors. (1993) (278)
Opiate receptor binding sites in human brain (1982) (272)
On the central sites for the antinociceptive action of morphine and fentanyl. (1970) (269)
Activation of hypothalamic β-endorphin pools by reward induced by highly palatable food (1983) (243)
Intrinsic mechanisms of antinociception in inflammation: local opioid receptors and beta-endorphin (1990) (226)
Novel opioid peptides derived from hemoglobin: hemorphins. (1986) (206)
Inflammation of the hind limb as a model of unilateral, localized pain: influence on multiple opioid systems in the spinal cord of the rat (1988) (196)
Development of physical dependence on morphine in respect to time and dosage and quantification of the precipitated withdrawal syndrome in rats (1973) (187)
Antinociceptive effects of μ- and κ-agonists in inflammation are enhanced by a peripheral opioid receptor-specific mechanism (1988) (186)
Place preference conditioning reveals the involvement of D1-dopamine receptors in the motivational properties of μ- and κ-opioid agonists (1987) (181)
Specificity of opioids towards the μ-, δ- and ϵ-opiate receptors (1979) (180)
In vivo RECEPTOR BINDING OF THE OPIATE PARTIAL AGONIST, BUPRENORPHINE, CORRELATED WITH ITS AGONISTIC AND ANTAGONISTIC ACTIONS (1981) (176)
Motivational properties of opioids: evidence that an activation of σ-receptors mediates reinforcement processes (1987) (171)
The endocrinology of the opioids. (1985) (171)
Regional distribution of methionine-enkephalin- and beta-endorphin-like immunoreactivity in human brain and pituitary (1979) (168)
Endocrine actions of opioids. (1984) (166)
Stress-induced release of brain and pituitary β-endorphin: Major role of endorphins in generation of hyperthermia, not analgesia (1981) (160)
Motivational effects of opioids: influence of D-1 versus D-2 receptor antagonists. (1988) (157)
A model of chronic pain in the rat: response of multiple opioid systems to adjuvant-induced arthritis (1986) (154)
Multiple opiate receptors in peripheral tissue preparations. (1981) (150)
Opioid reward mechanisms: a key role in drug abuse? (1998) (150)
POSSIBLE ANTIDEPRESSIVE EFFECTS OF OPIOIDS: ACTION OF BUPRENORPHINE (1982) (149)
Differential effects of acute and chronic ethanol treatment on particular opioid peptide systems in discrete regions of rat brain and pituitary (1983) (146)
Dopaminergic regulation of striatal proenkephalin mrna and prodynorphin mrna: Contrasting effects of d1 and d2 antagonists (1988) (146)
Selective receptors for β-endorphin on the rat vas deferens (1979) (146)
Stimulation of hypothalamic β-endorphin and dynorphin release by corticotropin-releasing factor (in vitro) (1986) (145)
beta-Endorphin-like immunoreactivity in cerebrospinal fluid and plasma of patients with schizophrenia and other neuropsychiatric disorders. (1979) (145)
Comparison of in vivo and in vitro parameters of opiate receptor binding in naive and tolerant dependent rodents. (1975) (145)
Mixed opioid/nonopioid effects of dynorphin and dynorphin related peptides after their intrathecal injection in rats (1983) (141)
β-Endorphin and dynorphin control serum luteinizing hormone level in immature female rats (1981) (141)
Involvement of endorphins in emotional hyperthermia of rats. (1978) (136)
Dynorphin-related immunoreactive peptides in rat brain and pituitary (1980) (132)
Pharmacological characterization of the epsilon-opiate receptor. (1981) (131)
Peripheral mechanisms of opioid antinociception in inflammation: involvement of cytokines. (1993) (129)
Spontaneous association between opioid receptors and GTP-binding regulatory proteins in native membranes: specific regulation by antagonists and sodium ions. (1990) (129)
Peripheral effect of fentanyl upon nociception in inflamed tissue of the rat (1988) (127)
Indication of an antipsychotic action of the opiate antagonist naloxone. (1977) (127)
Selective development of tolerance without dependence in multiple opiate receptors of mouse vas deferens (1980) (127)
The opioid peptide dynorphin, circadian rhythms, and starvation. (1983) (125)
Prodynorphin gene expression is enhanced in the spinal cord of chronic arthritic rats (1987) (123)
A model of chronic pain in the rat: functional correlates of alterations in the activity of opioid systems (1987) (120)
Aspects of opiate dependence in the myenteric plexus of the guinea-pig. (1976) (120)
The influence of microelectrophoretically applied biogenic amines, cholinomimetics and procaine on synaptic excitation in the corpus striatum. (1968) (120)
Differential effects of mu and kappa opioid systems on motivational processes. (1986) (115)
beta-Endorphin-like immunoreactivity in plasma, pituitaries and hypothalamus of rats following treatment with opiates. (1978) (115)
Buprenorphine: differential interaction with opiate receptor subtypes in vivo. (1982) (113)
Acute and chronic ethanol treatment changes endorphin levels in brain and pituitary (2004) (113)
Pro-opiocortin fragments in human and rat brain: β-endorphin and α-MSH are the predominant peptides (1980) (113)
Electrical stimulation in vivo increases the expression of proenkephalin mRNA and decreases the expression of prodynorphin mRNA in rat hippocampal granule cells. (1988) (112)
Parallel distribution of immunoreactive α-neo-endorphin and dynorphin in rat and human tissue (1982) (107)
Drugs and the conditioned avoidance response. (1960) (107)
Opioid peptide-like immunoreactivity localized in GABAErgic neurons of rat neostriatum and central amygdaloid nucleus. (1983) (105)
Involvement of central μ and δ opioid receptors in mediating the reinforcing effects of β-endorphin in the rat (1990) (103)
Evidence for a Selective Processing of Proenkephalin B into Different Opioid Peptide Forms in Particular Regions of Rat Brain and Pituitary (1984) (102)
Evidence that the aversive effects of opioid antagonists and κ-agonists are centrally mediated (2004) (102)
Corticotropin-releasing factor (CRF) inhibits gonadotropin-releasing hormone (GnRH) release from superfused rat hypothalami in vitro (1986) (101)
Levels of dynorphin-(1-13) immunoreactivity in rat neurointermediate pituitaries are concomitantly altered with those of leucine enkephalin and vasopressin in response to various endocrine manipulations. (1981) (100)
The role of CRF in the release of ACTH by opiate agonists and antagonists in rats (1987) (98)
Antagonist-induced opioid receptor up-regulation. II. Regionally specific modulation of mu, delta and kappa binding sites in rat brain revealed by quantitative autoradiography. (1988) (97)
Induction of the gene encoding pro-dynorphin by experimentally induced arthritis enhances staining for dynorphin in the spinal cord of rats (1989) (97)
Opiate receptor binding sites in human spinal cord (1983) (96)
A non-beta-endorphinergic adenohypophyseal mechanism is essential for an analgetic response to stress. (1980) (95)
Enkephalin-induced inhibition of cortical neurones and the lack of this effect in morphine tolerant/dependent rats (1976) (95)
Evidence for the involvement of endogenous opioids in the inhibition of luteinizing hormone by corticotropin-releasing factor. (1988) (94)
The direction of opioid agonists towards μ-, δ- and ε-receptors in the vas deferens of the mouse and the rat (1980) (94)
Endorphinergic modulation of neural reward systems indicated by behavioral changes (1984) (91)
Conditioning of Opioid Reinforcement: Neuroanatomical and Neurochemical Substrates (1992) (89)
Actions of opiates upon single unit activity in the cortex of naive and tolerant rats (1976) (88)
Electrically stimulated release of opiate-like material from the myenteric plexus of the guinea pig ileum. (1977) (87)
Dynorphin, a preferential ligand for κ-opioid receptors, is present in nerve fibers and immune cells within inflamed tissue of the rat (1992) (86)
Characterization and localization of immunoreactive dynorphin, α-neo-endorphin, met-enkephalin and substance P in human spinal cord (1983) (86)
Localization of prodynorphin messenger RNA in rat brain by in situ hybridization using a synthetic oligonucleotide probe (1986) (86)
Kappa-opioid receptor-mediated antinociception in the rat. II. Supraspinal in addition to spinal sites of action. (1989) (85)
The demonstration in vivo of specific binding sites for neuroleptic drugs in mouse brain (1977) (85)
THE IMPORTANCE OF LIPID-SOLUBILITY FOR THE CENTRAL ACTION OF CHOLINOLYTIC DRUGS. (1965) (84)
Antagonist-induced opioid receptor up-regulation. I. Characterization of supersensitivity to selective mu and kappa agonists. (1988) (83)
Antinociceptive potencies of β-casomorphin analogs as compared to their affinities towards μ and δ opiate receptor sites in brain and periphery (1982) (83)
A selective distribution pattern of different opiate receptors in certain areas of rat brain as revealed by in vitro autoradiography (1981) (83)
Analgesic effects of μ-, δ- and κ-opiate agonists and, in particular, dynorphin at the spinal level (1983) (83)
Immunoreactive dynorphin in human brain and pituitary (1982) (82)
Discrimination of three opiate receptor binding sites with the use of a computerized curve-fitting technique. (1982) (80)
Chronic haloperidol treatment increases the level of in vitro translatable messenger ribonucleic acid coding for the beta-endorphin/adrenocorticotropin precursor proopiomelanocortin in the pars intermedia of the rat pituitary. (1982) (80)
Identification of the opioid receptor types mediating beta-endorphin-induced alterations in dopamine release in the nucleus accumbens. (1990) (79)
Modulation of in vitro release of beta-endorphin from the separate lobes of the rat pituitary. (1979) (78)
Studies on the central antinociceptive action of cholinomimetic agents. (1969) (77)
Benzodiazepines modulate striatal enkephalin levels via a GABAergic mechanism. (1980) (76)
Stress-induced alterations in the levels of messenger RNA coding for proopiomelanocortin and prolactin in rat pituitary. (1986) (75)
Peripheral opioid receptors mediating antinociception in inflammation. Activation by endogenous opioids and role of the pituitary-adrenal axis (1990) (74)
In vivo receptor occupation by benzodiazepines and correlation with the pharmacological effect (1979) (73)
Long-term morphine treatment decreases endorphin levels in rat brain and pituitary (1979) (73)
Effects of morphine on the turnover of brain catecholamines and serotonin in rats-acute morphine administration. (1975) (69)
Opiate agonist-antagonist interaction at cortical neurones of naive and tolerant/dependent rats. (1974) (69)
Evidence that the aversive effects of opioid antagonists and kappa-agonists are centrally mediated. (1989) (68)
Buprenorphrine: demonstration of physical dependence liability. (1981) (68)
Demonstration and distribution of an opiate binding site in rat brain with high affinity for ethylketocyclazocine and SKF 10,047. (1981) (68)
A subclassification of κ-sites in human brain by use of dynorphin 1–17 (1981) (68)
Spinal cord dynorphin may modulate nociception via a ℵ-opioid receptor in chronic arthritic rats (1985) (67)
Naloxone blocks the effect of diazepam and meprobamate on conflict behaviour in rats (1981) (67)
The influence of foot-shock stress upon brain, pituitary and spinal cord pools of immunoreactive dynorphin in rats (1981) (67)
GTPase and adenylate cyclase desensitize at different rates in NG108-15 cells. (1987) (66)
Opiate Receptor: Multiple Effects of Metal Ions (1982) (66)
Binding Characteristics of a Monoclonal β‐Endorphin Antibody Recognizing the N‐Terminus of Opioid Peptides (1983) (65)
Motivational effects of opioids in an animal model of prolonged inflammatory pain: alteration in the effects of κ-but not of μ-receptor agonists (1988) (64)
H1-histaminergic activation stimulates inositol-1-phosphate accumulation in chromaffin cells. (1986) (63)
H1-histaminergic activation of catecholamine release by chromaffin cells. (1988) (63)
Functional opiate receptors in the guinea-pig ileum: their differentiation by means of selective tolerance development. (1981) (62)
Lesions of the hypothalamic arcuate nucleus produce a temporary hyperalgesia and attenuate stress-evoked analgesia. (1980) (61)
Regulation of striatal prodynorphin mRNA levels by the raphe-striatal pathway. (1988) (61)
Place preference conditioning reveals the involvement of D1-dopamine receptors in the motivational properties of mu- and kappa-opioid agonists. (1987) (61)
Molecular requirements involved in suppression of EAE by synthetic basic copolymers of amino acids. (1976) (61)
Intrathecally administered dynorphin-(1-17) modulates morphine-induced antinociception differently in morphine-naive and morphine-tolerant rats. (1987) (60)
The influence of chronic stress on multiple opioid peptide systems in the rat: pronounced effects upon dynorphin in spinal cord (1987) (60)
Evidence for the occurrence of the opioid octapeptide dynorphin-(1-8) in the neurointermediate pituitary of rats. (1981) (59)
ANTIDEPRESSANT EFFECTS OF BUPRENORPHINE (1982) (59)
Activation of periaqueductal grey pools of β-endorphin by analgetic electrical stimulation in freely moving rats (1987) (59)
Lack of cross-tolerance on multiple opiate receptors in the mouse vas deferens. (1980) (57)
Effects of Chronic Ethanol Treatment on the In Vitro Biosynthesis of Pro‐Opiomelanocortin and ItsPosttranslational Processing to (β‐Endorphin in theIntermediate Lobe of the Rat Pituitary (1984) (57)
Novel opioid peptides derived from mitochondrial cytochrome b: cytochrophins. (1985) (57)
Distribution and characterization of opioid peptides derived from proenkephalin A in human and rat central nervous system (1984) (57)
Selective localization of different types of opiate receptors in hippocampus as revealed by in vitro autoradiography (1981) (56)
Feedback inhibition of opioid peptide release in the hypothalamus of the rat (1987) (55)
Highly specific opiate receptors for dynorphin-(1-13) in the mouse vas deferens. (1980) (55)
Potassium-induced release of enkephalins from rat striatal slices. (1978) (55)
Preference conditioning produced by opioid active and inactive isomers of levorphanol and morphine in rat. (1986) (54)
Autoradiographic localization in rat brain of κ opiate binding sites labelled by [3Hbremazocine (1986) (54)
Vasopressin and oxytocin in the rat spinal cord: analysis of their role in the control of nociception (1984) (54)
Concomitant changes in the in vitro and in vivo release of opioid peptides and luteinizing hormone-releasing hormone from the hypothalamus following blockade of receptors for corticotropin-releasing factor. (1988) (54)
[3H]diprenorphine receptor binding in vivo and in vitro. (1982) (54)
β-Endorphin-induced locomotor stimulation and reinforcement are associated with an increase in dopamine release in the nucleus accumbens (2005) (54)
Pertussis toxin abolishes the antinociception mediated by opioid receptors in rat spinal cord. (1987) (53)
Vasopressin and oxytocin in the rat spinal cord: Distribution and origins in comparison to [met]enkephalin, dynorphin and related opioids and their irresponsiveness to stimuli modulating neurohypophyseal secretion (1984) (53)
Intracellular studies on the action of L-glutamic acid on spinal neurones of the cat. (1972) (53)
Enhanced activity of the beta-endorphinergic system in the anterior and neurointermediate lobe of the rat pituitary after chronic treatment with ethanol liquid diet. (1984) (52)
Evidence that the discriminative stimulus properties of fentanyl and ethylketocyclazocine are mediated by an interaction with different opiate receptors. (1982) (52)
Changes of cutaneous receptive fields of spino-cervical-tract neurones and other dorsal horn neurones by microelectrophoretically administered amino acids (2004) (52)
Release of immunoreactive-dynorphin from the isolated guinea-pig small intestine is reduced during peristaltic activity (1981) (52)
Involvement of capsaicin-sensitive neurones in hyperalgesia and enhanced opioid antinociception in inflammation (1990) (52)
Central kappa- and mu-opiate receptors mediate ACTH-release in rats. (1985) (51)
Antinociceptive effects of mu- and kappa-agonists in inflammation are enhanced by a peripheral opioid receptor-specific mechanism. (1988) (51)
Pharmacokinetics of fentanyl in rabbits in view of the importance for limiting the effect. (1971) (51)
Opiate activity and receptor selectivity of dynorphin1–13 and related peptides (1980) (50)
Specific changes in local cerebral glucose utilization in the rat brain induced by acute and chronic diazepam (1985) (50)
Neurobiology of Opioids (1991) (49)
Calcium reverses the inhibitory action of morphine on neuroeffector transmission in the mouse vas deferens (1980) (48)
Opioid receptors are coupled tightly to G proteins but loosely to adenylate cyclase in NG108-15 cell membranes. (1988) (47)
Prodynorphin gene expression in spinal cord is enhanced after traumatic injury in the rat. (1988) (47)
Aversive properties of naloxone in non-dependent (naive) rats may involve blockade of central β-endorphin (2004) (47)
Control of opiate receptor numberin vivo: Simultaneous κ-receptor down-regulation and μ-receptor up-regulation following chronic agonist/antagonist treatment (1989) (47)
Peripheral opioid receptors mediating antinociception in inflammation. Evidence for activation by enkephalin-like opioid peptides after cold water swim stress. (1990) (47)
Isolation and structure of a novel C-terminally amidated opioid peptide, amidorphin, from bovine adrenal medulla (1985) (46)
Proenkephalin B (prodynorphin)-derived opioid peptides: evidence for a differential processing in lobes of the pituitary. (1984) (46)
Chronic ethanol imbibition interferes with δ-, but not with μ-opiate receptors (1981) (46)
Pharmacologically induced alterations of cortical and subcortical evoked potentials compared with physiological changes during the awake-sleep cycle in cats. (1967) (46)
Opioid tolerance and dependence: re-evaluating the unitary hypothesis (1985) (46)
Differential regulation of the mu-, delta-, and kappa-opiate receptor subtypes by guanyl nucleotides and metal ions (1982) (45)
A DEMONSTRATION OF NALOXONE‐PRECIPITATED OPIATE WITHDRAWAL ON SINGLE NEURONES IN THE MORPHINE‐TOLERANT/DEPENDENT RAT BRAIN (1980) (45)
Differentiation of opiate receptors in the brain by the selective development of tolerance (1981) (44)
Opiate suppression of LH secretion involves central receptors different from those mediating opiate effects on prolactin secretion. (1987) (44)
Inquiry into endorphinergic feedback mechanisms during the development of opiate tolerance/dependence (1980) (44)
The influence of selective adeno- and neurointermedio-hypophysectomy upon plasma and brain levels of ß-endorphin and their response to stress in rats (1982) (44)
A two-step mechanism by which corticotropin-releasing hormone releases hypothalamic beta-endorphin: the role of vasopressin and G-proteins. (1989) (43)
Opiate agonist action of antidiarrheal agents in vitro and in vivo—Findings in support for selective action (2004) (43)
Endogenous opioids, circadian rhythms, nutrient deprivation, eating and drinking. (1982) (43)
Facilitation of ACTH secretion by morphine is mediated by activation of CRF releasing neurons and sympathetic neuronal pathways (1989) (43)
Endogenous ligands for κ-opiate receptors (1982) (43)
Specific versus non-specific actions of opioids on hippocampal neurones in the rat brain (1979) (42)
Non-opioid psychotomimetic-like discriminative stimulus properties of N-allylnormetazocine (SKF 10,047) in the rat. (1982) (42)
Binding of opiates and endogenous opioid peptides to neuroleptic receptor sites in the corpus striatum. (1978) (42)
Diazepam-induced release of opioid activity in the rat brain (1980) (42)
Co-localization of proenkephalin- and prodynorphin-derived opioid peptides in laminae IV/V spinal neurons revealed in arthritic rats (1988) (41)
Differentiation between spinal and supraspinal sites of action of morphine when inhibiting the hindleg flexor reflex in rabbits. (1973) (40)
Developments in opiate research (1978) (40)
Interaction of amphetamine and naloxone in feeding behavior in guinea pigs. (1980) (40)
Release of β-endorphin from rat hypothalamus in vitro (1979) (40)
The hypothalamic paraventricular nucleus: relationship to brain and pituitary pools of vasopressin and oxytocin as compared to dynorphin, beta-endorphin and related opioid peptides in the rat. (1984) (39)
Effect of interpleural morphine on postoperative pain and pulmonary function after thoracotomy. (1992) (39)
Opioid peptides derived from pro-enkephalin A but not that from pro-enkephalin B are substantial analgesics after administration into brain of mice. (1982) (39)
Interaction between morphine and putative excitatory neurotransmitters in cortical neurons in naive and tolerant rats. (1975) (39)
Depletion of central β-endorphin blocks midbrain stimulation produced analgesia in the freely-moving rat (1986) (38)
Autoradiographic studies concerning the supraspinal site of the antinociceptive action of morphine when inhibiting the hindleg flexor reflex in rabbits. (1973) (38)
Neuroanatomical substrates mediating the aversive effects of D-1 dopamine receptor antagonists (2005) (38)
Chapter 7 Peripheral opioid analgesia - facts and mechanisms (1996) (38)
Monoclonal antibody to the message sequence Tyr-Gly-Gly-Phe of opioid peptides exhibits the specificity requirements of mammalian opioid receptors. (1983) (38)
Immunoreactive dynorphin in the rat adenohypophysis consists exclusively of 6000 dalton species. (1981) (37)
Non-competitive nature of the antagonistic mechanism responsible for tolerance development to opiate-induced analgesia (1979) (36)
Low permeation of systemically administered human ß-endorphin into rabbit brain measured by radioimmunoassays differentiating human and rabbit ß-endorphin (1980) (36)
Receptor binding and biological activity of bivalent enkephalins. (1985) (36)
Pharmacokinetics of fentanyl in man and the rabbit (1972) (36)
A model of chronic pain in the rat: high-resolution neuroanatomical approach identifies alterations in multiple opioid systems in the periaqueductal grey (1987) (36)
Tolerance and cross-tolerance to the discriminative stimulus properties of fentanyl and morphine. (1988) (35)
Neurochemical Aspects of Addiction: Opioids and Other Drugs of Abuse (1989) (35)
Electrophoretic release of tritium-labelled glutamic acid from micropipettes in vitro. (1969) (35)
Pro-enkephalin intermediates in bovine brain and adrenal medulla: characterization of immunoreactive peptides related to BAM-22P and peptide F. (1982) (34)
Opioid modulation of LHRH release in vitro depends upon levels of testosterone in vivo. (1986) (34)
Inhibition of behavioural and EEG activation induced by morphine acting on lower brain-stem structures. (1972) (34)
Monoclonal anti-idiotypic antibodies to opioid receptors. (1988) (34)
Corticotropin-releasing factor stimulates the release of methionine-enkephalin and dynorphin from the neostriatum and globus pallidus of the rat: in vitro and in vivo studies (1989) (33)
▽ E Phe4‐enkephalin analogs Delta receptors in rat brain are different from those in mouse vas deferens (1987) (33)
Opioid peptides in Huntington's disease: Alterations in prodynorphin and proenkephalin system (1986) (33)
Discriminative stimulus properties of bremazocine in the rat (1981) (33)
Release of β-endorphin from rat pituitary in vitro (1978) (33)
Opioid receptor desensitization in NG 108-15 cells. Differential effects of a full and a partial agonist on the opioid-dependent GTPase. (1987) (33)
Pharmacological modulation of opiate-like peptide systems (1980) (32)
Postnatal development of beta-endorphin-related peptides in rat anterior and intermediate pituitary lobes: evidence for contrasting development of proopiomelanocortin processing. (1984) (31)
Continuous social defeat induces an increase of endogenous opioids in discrete brain areas of the mongolian gerbil (1985) (30)
Involvement of β-endorphin and μ-opioid receptors in mediating the aversive effect of lithium in the rat (1988) (30)
Contribution of the supra-optic nucleus to brain and pituitary pools of immunoreactive vasopressin and particular opioid peptides, and the interrelationships between these, in the rat. (1983) (30)
Histamine Affects Release and Biosynthesis of Opioid Peptides Primarily via H1‐Receptors in Bovine Chromaffin Cells (1987) (30)
Motivational effects of opioids in an animal model of prolonged inflammatory pain: alteration in the effects of kappa- but not of mu-receptor agonists. (1988) (30)
Sites of action of morphine involved in the development of physical dependence in rats (2004) (30)
Changes in local cerebral glucose utilization induced by the beta- carbolines FG 7142 and DMCM reveal brain structures involved in the control of anxiety and seizure activity (1987) (29)
Evidence for a role of the ventro-medial posterior hypothalamus in nociceptive processes in the rat (1983) (29)
Subcellular distribution of enkephalins and endogenous opioid activity in rat brain. (1978) (29)
In vivo opiate binding unchanged in tolerant/dependent mice. (1979) (28)
Des-Tyrosyl-γ-Endorphin in Schizophrenia (1980) (28)
Significance of Testosterone in Regulating Hypothalamic Content and In Vitro Release of β‐Endorphin and Dynorphin (1987) (28)
Pre- and postsynaptic actions of GABA on the release of hypothalamic gonadotropin-releasing hormone (GnRH) (1988) (27)
Tolerance and selective cross-tolerance to the motivational effects of opioids (1988) (27)
Role of catecholaminergic mechanisms in the expression of the morphine abstinence syndrome in rats (2004) (27)
Presynaptic auto- and allelo-receptor regulation of hypothalamic opioid peptide release (1989) (27)
Multiple states of opioid receptors may modulate adenylate cyclase in intact neuroblastoma X glioma hybrid cells. (1985) (27)
Multiple opiate receptors and their functional significance. (1983) (27)
In vivo receptor occupation by opiates and correlation to the pharmacological effect. (1978) (26)
Involvement of central mu and delta opioid receptors in mediating the reinforcing effects of beta-endorphin in the rat. (1990) (26)
Radioimmunoassay of β-endorphin basal and stimulated levels in extracted rat plasma (1978) (26)
Sodium modulates opioid receptors through a membrane component different from G-proteins. Demonstration by target size analysis. (1988) (26)
Beta-endorphin and dynorphin control serum luteinizing hormone level in immature female rats. (1981) (26)
Microelectrophoretic studies concerning the spread of glutamic acid and GABA in brain tissue (2004) (25)
A highly selective ligand for brain δ opiate receptors, a ▿ E Phe4‐enkephalin analog, suppresses μ receptor‐mediated thermal analgesia by morphine (1988) (25)
Local opioid receptors mediating antinociception in inflammation: endogenous ligands. (1990) (25)
Diazepam effects on striatal met-enkephalin levels following long-term pharmacological manipulations (1980) (25)
Sites of action of morphine involved in the development of physical dependence in rats (1976) (25)
CORTICAL AND SUBCORTICAL AUDITORY EVOKED POTENTIALS DURING WAKEFULNESS AND SLEEP IN THE CAT. (1965) (25)
Morphine-induced place conditioning is not confounded by drug-induced alterations in locomotor activity (1989) (25)
Endogenous opioid peptides in the descending control of nociceptive responses of spinal dorsal horn neurons. (1988) (25)
Distinct distribution of opioid receptor types in rat lumbar spinal cord (1987) (25)
Autoradiographic evaluation of the intracerebral distribution of 3-H-etorphine in the mouse brain. (1975) (24)
Detection of a long acting endogenous opioid in blood and small intestine. (1977) (24)
Hypothalamic opioid receptors mediate the inhibitory actions of corticotropin-releasing hormone on luteinizing hormone release: further evidence from a morphine-tolerant animal model (1988) (23)
Interaction between morphine and morphine antagonists after systemic and intraventricular application. (1970) (23)
Multiple Factors Influencing the In Vitro Release of [Met5]‐Enkephalin from Rat Hypothalamic Slices (1989) (23)
The selective kappa-opioid agonist, U-50,488H, produces antinociception in the rat via a supraspinal action. (1987) (23)
Rapid changes in enkephalin levels in rat striatum and hypothalamus induced by diazepam (1979) (23)
Endogenous opioids and addiction (1995) (22)
Regulation of luteinizing hormone secretion in prepubertal male and female rats. (1982) (22)
Is there some indication from behavioral effects of endorphins for their involvement in psychiatric disorders? (1978) (22)
Opioid dependence in the guinea-pig myenteric plexus is controlled by non-tolerant and tolerant opioid receptors. (1985) (22)
Immunocytochemical demonstration of opioid receptors in selected rat brain areas and neuroblastoma × glioma hybrid (NG108-15) cells using a monoclonal anti-idiotypic antibody (1989) (22)
Iontophoretic release of substances from micropipettes in vitro. (1974) (21)
Effect of 6-hydroxydopamine, 5,6-dihydroxytryptamine and raphe lesions on the antinociceptive actions of morphine in rats (1973) (21)
Foot shock stress-induced release of vasopressin in adenohypophysectomized and hypophysectomized rats. (1985) (21)
Inhibition of specific opiate binding to synaptic membrane by cerebroside sulfatase. (1979) (21)
Actions of naloxone in different types of psychoses (1979) (21)
Peptide neuroanatomy of adjuvant-induced arthritic inflammation in rat (1988) (21)
Opiate antagonist--receptor interaction unchanged by acute or chronic opiate treatment. (1979) (21)
Demonstration and characterization of alpha-human atrial natriuretic factor in human plasma. (1985) (20)
Centrally and peripherally mediated inhibition of intestinal motility by opioids (1979) (20)
Functional Response of Multiple Opioid Systems to Chronic Arthritic Pain in the Rat a (1986) (20)
Opioid antinociception and positive reinforcement are mediated by different types of opioid receptors. (1983) (20)
Opioid dependence and cross-dependence in the isolated guinea-pig ileum. (1982) (20)
Dependence liability of enkephalin in the myenteric plexus of the guinea pig. (1976) (20)
Excitation and inhibition of cholinoceptive brain structures and its relationship to pharmacological induced behaviour changes (1963) (20)
Stimulation of acid secretion and phosphoinositol production by rat parietal cell muscarinic M2 receptors. (1988) (19)
Evidence for the epsilon-type of opioid receptor in the rat vas deferens. (1985) (19)
Opioid gene expression in rat striatum is modulated via opioid receptors: Evidence from localized receptor inactivation (1988) (19)
DES-TYR1-γ-ENDORPHIN IN SCHIZOPHRENIA (1980) (19)
Opioids and opioid receptors mediating antinociception at various levels of the neuraxis. (1990) (18)
Hypothalamic LH-RH release after acute and chronic treatment with morphine studied in a combined in vivo/in vitro model (1988) (18)
Influence of chronic lithium treatment upon the motivational effects of opioids: alteration in the effects of mu- but not kappa-opioid receptor ligands. (1991) (18)
Opioids and Motivation (1987) (18)
Supersensitivity to opioids following the chronic blockade of endorphin action by naloxone (2004) (18)
Target size analysis of opioid receptors. No difference between receptor types, but discrimination between two receptor states. (1986) (18)
Changes in striatal dopamine metabolism during precipitated morphine withdrawal. (1977) (18)
Long‐Term Treatment of Rats with Morphine Reduces the Activity of Messenger Ribonucleic Acid Coding for the β‐Endorphin/ACTH Precursor in the Intermediate Pituitary (1982) (18)
Stimulation of hypothalamic opioid peptide release by lithium is mediated by opioid autoreceptors: Evidence from a combined in vitro, ex vivo study (1990) (17)
Sites of action of morphine involved in the development of physical dependence in rats (1977) (17)
Evidence for a differential postnatal development of proenkephalin B (= prodynorphin)-derived opioid peptides in the rat hypothalamus. (1984) (17)
The role of dopamine in withdrawal jumping in morphine dependent rats. (1976) (17)
The role of the ventral noradrenergic bundle in relation to endorphins in the control of core temperature, open-field and ingestive behaviour in the rat (1983) (17)
Role of immune processes in peripheral opioid analgesia. (1995) (17)
D-Ala2, D-Leu5-enkephalin generalizes to a discriminative stimulus produced by fentanyl but not ethylketocyclazocine (1982) (16)
Sodium chloride imbibition decreases levels of immunoreactive dynorphin in the neurointermediate pituitary of rats. (1980) (16)
Autoradiographic distribution in rat brain of a non-conventional binding site for the opiate [3]diprenorphine (1986) (16)
Specificity of opioids towards the mu-, delta- and epsilon-opiate receptors. (1979) (16)
Analgesic effects of mu-, delta- and kappa-opiate agonists and, in particular, dynorphin at the spinal level. (1983) (16)
Evidence that μ-opioid receptors mediate midbrain “stimulation-produced analgesia” in the freely moving rat (1987) (16)
The development of opiate tolerance may dissociate from dependence. (1982) (16)
Proenkephalin-A-derived peptides are present in human brain. (1983) (15)
Characteristics of a monoclonal beta-endorphin antibody recognizing the N-terminus of opioid peptides. (1982) (15)
Chronic pain in the rat: Selective alterations in CNS and pituitary pools of dynorphin as compared to vasopressin (1985) (15)
β-Endorphin-(1-27) is a naturally occurring antagonist of the reinforcing effects of opioids (1988) (15)
Extrahypothalamic Corticotropin and α-Melanotropin in Human Brain (1980) (15)
Intracerebral distribution pattern of radioactive morphine and morphine-like drugs after intraventricular and intrathecal injection (1970) (15)
Central serotonergic mechanisms and development of morphine dependence. (1976) (15)
Desensitization of opioid-stimulated GTPase in neuroblastoma x glioma hybrid cells. (1985) (15)
DEMONSTRATION AND CHARACTERIZATION OF A STEREOSPECIFIC OPIATE RECEPTOR IN THE NEUROBLASTOMA N18TG2 CELLS (1979) (15)
Prolonged inflammatory pain modifies corticotropin-releasing factor-induced opioid peptide release in the hypothalamus (1991) (15)
[Neurobiological principles of drug dependence. Exemplified by opioids and psychostimulants]. (1995) (15)
Lesions of the ventral noradrenergic (norepinephrinergic) bundle affect brain and pituitary pools of endorphins and the response of these to stress in rats. (1982) (15)
Effects of morphine on the turnover of brain catecholamines and serotonin in rats-chronic morphine administration. (1975) (14)
Motivational properties of opioids. (1987) (14)
A 'window of time' during which testosterone determines the opiatergic control of LH release in the adult male rat. (1987) (14)
Paradoxical LH and prolactin responses to naloxone after chronic treatment with morphine. (1986) (14)
The opiate-like action of tilidine is mediated by metabolites (1978) (14)
Influence of meprobamate and phenobarbital upon local cerebral glucose utilization: parallelism with effects of the anxiolytic diazepam (1987) (14)
Opioid components of the clockwork that governs luteinizing hormone and prolactin release in male rats (1988) (14)
Interactions of Opiates and Endorphins With Cerebral Catecholamines (1980) (14)
Precipitated morphine withdrawal in rats as a tool in opiate research. (1977) (14)
Concomitant neonatal development and in vitro release of dynorphin and α-neo-endorphin (1982) (14)
Naloxone-precipitated withdrawal reveals sensitization to neurotransmitters in morphine tolerant/dependent rats (1977) (14)
Modulation of the mesolimbic dopaminergic system by beta-endorphin-(1-27) as assessed by microdialysis. (1991) (14)
Sex-dependent endorphinergic and adrenergic control mechanisms of luteinizing hormone secretion in immature rats. (1985) (14)
Ontogenetic development of the pro-enkephalin B (= pro-dynorphin) opioid peptide system in the rat pituitary. (1984) (13)
Discriminative stimulus properties of narcotic and non-narcotic drugs in rats trained to discriminate opiate ϰ-receptor agonists (2004) (13)
Some actions of cholinergic and anticholinergic drugs on reactive behavior. (1968) (13)
An opioid antagonist stimulates myometrial activity in early postpartum cows. (1985) (13)
Cholecystokinin octapeptide activates an opioid mechanism in the guinea-pig ileum: a possible role for substance P. (1987) (13)
Comparison of withdrawal precipitating properties of various morphine antagonists and partial agonists in relation to their stereospecific binding to brain homogenates (2004) (13)
Limbic brain structures are important sites of κ-opioid receptor-mediated actions in the rat: a [14C]-2-deoxyglucose study (1989) (12)
OPIOID AGONISTS AND ANTAGONISTS: ACTION ON MULTIPLE OPIATE RECEPTORS (1980) (12)
Evidence for an interrelationship between ventral noradrenergic bundle and CNS endorphins in the control of nociception in the rat (1982) (12)
[Neurobiologic aspects of the morphine addictions]. (1974) (12)
Regulation of hypothalamic beta-endorphin and dynorphin release by corticotropin-releasing factor (CRF). (1986) (12)
Action of [Des-Tyr1]-γ-Endorphin in Schizophrenia (1981) (12)
Lack of cross-tolerance between morphine and Leu-enkephalin in the mouse vas deferens (1980) (12)
[Permeation of active morphine-like substances at their sites of antinociceptive action in the brain as a function of their lipid-solubility following intravenous and intraventricular application]. (1970) (12)
Chronic arthritis in the rat: Differential changes in discrete brain pools of vasopressin as compared to oxytocin (1985) (12)
Corticotropin-releasing factor is excitatory in the guinea-pig ileum and activates an opioid mechanism in this tissue. (1984) (12)
Neural activation of opioid mechanisms in guinea pig ileum by excitatory peptides. (1987) (12)
Fentanyl and morphine discrimination in rats continuously infused with fentanyl (1989) (12)
Nigrostriatal dopamine mediates the stimulatory effects of corticotropin releasing factor on methionine-enkephalin and dynorphin release from the rat neostriatum (1990) (12)
Opiate binding sites in bovine retina: evidence for benzomorphan selective binding sites. (1983) (12)
The role of the mediobasal arcuate hypothalamus in relation to opioid systems in the control of ingestive behaviour in the rat (1986) (11)
Role of endorphins in addiction. (1981) (11)
Novel Opioid Peptide Amidorphin: Characterization and Distribution of Amidorphin‐Like Immunoreactivity in Bovine, Ovine, and Porcine Brain, Pituitary, and Adrenal Medulla (1985) (11)
Receptor preference of dynorphin A fragments in the mouse vas deferens determined by different techniques. (1984) (11)
Studies on a Possible Pathological Significance of Endorphins in Psychiatric Disorders (1979) (11)
Peripheral opioid receptors mediating antinociception in inflammation: Localization on primary afferent neurons (1990) (11)
Release of opioid peptides from the spinal cord of rats subjected to chronic pain. (1986) (11)
Contrasting interactions of the locus coeruleus as compared to the ventral noradrenergic bundle with CNS and pituitary pools of vasopressin, dynorphin and related opioid peptides in the rat (1984) (11)
Selective receptors for beta-endorphin on the rat vas deferens. (1979) (11)
Radioimmunoassay of enkephalins (1977) (11)
Bidirectional effects of opioids in motivational processes and the involvement of D1 dopamine receptors. (1988) (11)
Neuropeptides and other secretagogues in bovine chromaffin cells: Their effect on opioid peptide metabolism (1989) (11)
Opioid binding properties in bovine retina (1981) (11)
Paradoxical effect of chronic fentanyl treatment on naltrexone-induced supersensitivity and upregulation. (1992) (10)
A subclassification of multiple opiate receptors by means of selective tolerance development. (1983) (10)
Response of brain and pituitary pools of dynorphin as compared to vasopressin to acute stress in the rat. (1983) (10)
Involvement of beta-endorphin and mu-opioid receptors in mediating the aversive effect of lithium in the rat. (1988) (10)
Measurement of β-Endorphin-Like Immunoreactivity in CSF and Plasma of Neuropsychiatric Patients (1979) (10)
Plasma levels of beta-endorphin under chronic neuroleptic treatment in schizophrenic patients: failure of naloxone to counteract curative effects of neuroleptic drugs. (1980) (10)
Different types of opiate agonists interact distinguishably with mu, delta and kappa opiate binding sites. (1982) (10)
Selective destruction of the ventral noradrenergic bundle but not of the locus coeruleus elevates plasma levels of β-endorphin immunoreactivity in rats (1982) (10)
Analgesia, catatonia and changes in core temperature induced by opiates and endorphins: a comparison (1979) (10)
Excitatory neuropeptides activate opioid mechanisms in the guinea pig ileum (1985) (10)
Muscarinic M2‐receptors enhance polyphosphoinositol release in rat gastric mucosal cells (1986) (10)
Implications of the multiplicity of opioid receptors for the problem of addiction. (1990) (10)
Antinociceptive potencies of beta-casomorphin analogs as compared to their affinities towards mu and delta opiate receptor sites in brain and periphery. (1982) (10)
Opioid Receptors of Neuroblastoma Cells Are in Two Domains of the Plasma Membrane that Differ in Content of G Proteins (1989) (10)
Morphine abstinence syndrome in rabbits precipitated by injection of morphine antagonists into the ventricular system and restricted parts of it (2004) (10)
Changes in brain concentration of biogenic amines and the antinociceptive effect of morphine in rats (2004) (10)
Inability of naloxone to change brain morphine levels in tolerant mice. (1977) (9)
An analysis of the ‘tolerance’ which develops to analgetic electrical stimulation of the midbrain periaqueductal grey in freely moving rats (1987) (9)
Independent origin and modulation of vasopressin as compared to dynorphin and α-neo-endorphin in the medulla-pons of the rat (1982) (9)
Opioid tolerance and dependence in light of the multiplicity of opioid receptors. (1984) (9)
Neurotensin affects metabolism of opioid peptides, catecholamines and inositol phospholipids in bovine chromaffin cells. (1989) (9)
Evidence for an opiate-inactive N-acetylated derivative of leucine-enkephalin in the rat neurointermediate pituitary. (1981) (9)
Measurement of beta-endorphin-like immunoreactivity in CSF and plasma of neuropsychiatric patients. (1979) (8)
Differential distribution, release, and modulation of dynorphin and beta-endorphin. (1982) (8)
Des-tyrosyl-gamma-endorphin in schizophrenia: a double-blind trial in 13 patients. (1980) (8)
CENTRAL NICOTINE‐AND MUSCARINELIKE PROPERTIES OF CHOLINOMIMETIC DRUGS WITH REGARD TO THEIR LIPID SOLUBILITIES (1967) (8)
Supersensitivity of cortical neurones of the rat to acetylcholine and L-glutamate following chronic morphine treatment (2004) (8)
Differential Sensitivity of Basal and Opioid‐Stimulated Low Km GTPase to Guanine Nucleotide Analogs (1986) (8)
On the Role of Endorphins in Addiction (1982) (8)
Effects of depletion of brain catecholamines during the development of morphine dependence on precipitated withdrawal in rats (2004) (8)
Neuropharmacological analysis of the control of LH secretion in gonadectomized male and female rats: altered hypothalamic responses to inhibitory neurotransmitters in long-term castrated rats. (1988) (8)
Arthritic inflammation in rats as a model of chronic pain: role of opioid systems. (1989) (8)
Dynorphin‐Related Opioid Peptides in the Neurointermediate Pituitary of Rats Are Not α‐N‐Acetylated (1982) (8)
Opioid Systems and the Regulation of Mood: Possible Significance in Depression? (1983) (8)
Development of tolerance to the antinociceptive effect of morphine after intraventricular injection (1973) (8)
Chronic ethanol imbibition interferes with delta-, but not with mu-opiate receptors. (1981) (8)
Autoradiographic localization in rat brain of kappa opiate binding sites labelled by [3H]bremazocine. (1986) (8)
Tolerance and dependence induced by morphine-like pituitary peptides in rats (1976) (7)
Development of fields of focal potentials in the caudate nucleus following micro-electrophoretic application of glutamic acid and gaba. (1970) (7)
Spinal cord dynorphin may modulate nociception via a kappa-opioid receptor in chronic arthritic rats. (1985) (7)
Ethanol and tetrahydroisoquinoline alkaloids do not produce narcotic discriminative stimulus effects (2004) (7)
Opioid modulation of the discriminative stimulus produced by pentylenetetrazol (2004) (7)
In vivo modulation of rat hypothalamic opioid peptide content by intracerebroventricular injection of guanidinoethylmercaptosuccinic acid (GEMSA): possible physiological role of enkephalin convertase (1989) (7)
Peripheral opioid analgesia--facts and mechanisms. (1996) (7)
Analgesic Effect of Intraarticular Morphine After Arthroscopic Knee Surgery (1992) (7)
Discriminative stimulus properties of narcotic and non-narcotic drugs in rats trained to discriminate opiate kappa-receptor agonists. (1982) (7)
Control of opiate receptor number in vivo: simultaneous kappa-receptor down-regulation and mu-receptor up-regulation following chronic agonist/antagonist treatment. (1989) (7)
THE ACTIVATION OF ENDORPHIN(S) BY REWARD (1980) (6)
Tachyphylaxis to enkephalin - tolerance and dependence at the single neurone level? (1978) (6)
[Opiate addiction. Pharmacologic and biochemical aspects]. (1992) (6)
SUBSTANTIAL AMOUNTS OF IMMUNOREACTIVE BAM-12P AND BAM-22P ARE PRESENT IN BOVINE ADRENAL MEDULLA BUT NOT IN THE BRAIN (1981) (6)
Characterization of proenkepahlin B-derived opioid peptides in the human hypothalamo-neurohypophyseal axis (1985) (6)
Differential effects of various opioid peptides on vasopressin and oxytocin release from the rat pituitary in vitro (1984) (6)
K+-evoked release of met-enkephalin from rat striatum in vitro: Effect of putative neurotransmitters and morphine (2004) (6)
Opiates, opioids and their receptors in the modulation of pain. (1987) (6)
Isolation and structure of a C-terminally amidated nonopioid peptide, amidorphin-(8-26), from bovine striatum: a major product of proenkephalin in brain but not in adrenal medulla. (1986) (6)
Potentiation of opiate action in neuroblastoma N18TG2 cells by lipid incorporation. (1982) (6)
Pharmacologic manipulation of brain and pituitary endorphin content and release. (1980) (5)
Selective uptake of 3H-6-hydroxydopamine by neurones of the central nervous system (1973) (5)
A differential interaction of putative μ-selective agonists with opiate binding sites in rat brain (1982) (5)
Endorphin-induced hyperthermia: Characterization of the exogenously and endogenously induced effects (1979) (5)
Endogenous ligands for kappa-opiate receptors. (1982) (5)
Single neurone studies of opioid tolerance and dependence (1978) (5)
[Endorphins: a key to understanding pain, addiction and mental disorders?]. (1979) (5)
The effect of the potent opiate agonist etorphine on local energy metabolism in the isolated perfused rat brain (1981) (5)
Synaptic excitation in the corpus striatum inhibited by microelectrophoretically administered dopamine (1966) (5)
Identification of opiate/receptor binding in vivo. (1976) (4)
Inhibition of LH release by CRF may be partially mediated through hypothalamic beta-endorphin release. (1986) (4)
Opiate Receptors, Their Endogenous Ligands and the Development of Tolerance/Dependence (1979) (4)
Functional aspects of endorphins. (1980) (4)
Generalization tests with intraventricularly applied pro-enkephalin B-derived peptides in rats trained to discriminate the opioid kappa receptor agonist ethylketocyclazocine (2004) (4)
Development of acute opioid tolerance and dependence in rat striatal neurones (1980) (4)
CLINICAL TRIAL OF DES‐TYROSYL‐γ‐ENDORPHIN IN MENTAL ILLNESS (1982) (4)
Iontophoresis and transmitter mechanisms in the mammalian central nervous system (1979) (4)
Localization of striatal opioid gene expression, and its modulation by the mesostriatal dopamine pathway: An in situ hybridization study (2008) (4)
Serotonin and dopamine turnover after acute and chronic morphine administration. (1974) (4)
Pro-opiocortin fragments in human and rat brain: beta-endorphin and alpha-MSH are the predominant peptides. (1980) (4)
IS ß-ENDORPHIN INVOLVED IN THE ANALGESIA GENERATED BY STRESS? (1980) (4)
Permeation of purine derivatives into the cerebrospinal fluid of dogs (2005) (4)
Depletion of central beta-endorphin blocks midbrain stimulation produced analgesia in the freely-moving rat. (1986) (4)
Site of naloxone-precipitated opiate withdrawal dissociates from that at which apomorphine reinitiates this phenomenon (1978) (4)
Lesions of the ventral noradrenergic bundle produce a naloxone-reversible antinociception and affect brain and pituitary pools of β-endorphin (1981) (4)
Experimental mono- and polyarthritis differentially intensify immunostaining of multiple proenkephalin- and prodynorphin-opioid peptides in lumbo-sacral spinal neurons of the rat (1988) (3)
Application of receptor theory provides further evidence for the existence of the epsilon-opioid receptor in rat vas deferens. (1984) (3)
PERIPHERAL OPIOID RECEPTORS MEDIATING ANALGESIA IN INFLAMMATION: ACTIVATION BY EXOGENOUS AGONISTS AND STRESS (1989) (3)
Opiate receptor binding studies in the mouse vas deferens exhibiting tolerance without dependence (1982) (3)
A highly selective ligand for brain delta opiate receptors, a cyclopropyl(E)Phe(4)-enkephalin analog, suppresses mu receptor-mediated thermal analgesia by morphine. (1988) (3)
Activity of the nigro-striatal dopaminergic system during precipitated morphine withdrawal investigated in rats with acute unilateral inactivation of the striatum (1976) (3)
Effects of sodium and GTP on the binding kinetics of [3H]diprenorphine in NG 108-15 cell membranes (1986) (3)
Lack of evidence for a role of endorphinergic mechanisms in mediating a discriminative stimulus produced by diazepam in rats (2004) (3)
Mixed type inhibition of [D-Ala2,D-Leu5]enkephalin binding to μ-opiate binding sites by μ-, but not by κ-opiate ligands (1982) (3)
Inhibition of nicotine-induced secretion from bovine chromaffin cells by the amidated C-terminal sequence of the opioid peptide amidorphin. (1987) (3)
[Opiate addiction: New perspectives in research (author's transl)]. (1979) (3)
Application of “receptor theory provides further evidence for the existence of the ϵ-opioid receptor in rat vas deferens (1984) (3)
Enhancement of δ- but not μ-opiate agonist binding by calcium (1982) (2)
Characterization and localization of immunoreactive dynorphin, alpha-neo-endorphin, Met-enkephalin and substance P in human spinal cord. (1983) (2)
Uptake Rates of Diffusive Samplers for VOC In Indoor Air Quality Analysis (2006) (2)
Concomitant neonatal development and in vitro release of dynorphin and alpha-neo-endorphin. (1982) (2)
Progress in opioid research. Proceedings of the 1986 International Narcotics Research Conference. (1986) (2)
Enkephalin-induced inhibition of cortical neurones effect in morphine tolerant/dependent rats and the lack of this (1976) (2)
A simple method for the separate estimation of labelled drugs and their metabolites by liquid scintillation counting. Some practical examples (1972) (2)
In vitro determination and differentiation of mouse teratocarcinoma toward myocardiogenesis. (1977) (2)
Neuronal aspects of opiate dependence and tolerance in comparison to central depressants. (1977) (2)
Proceedings: The influence of morphine tolerance/dependence on the interaction between morphine agonists and antagonists in vivo and in vitro. (1975) (2)
Evidence that mu-opioid receptors mediate midbrain "stimulation-produced analgesia" in the freely moving rat. (1987) (2)
Response of cns and pituitary pools of particular opioid peptides to chronic arthritic pain in the rat (1984) (2)
RELEASE OF ENDORPHINS AND THEIR MODULATION FROM RAT BRAIN IN VITRO (1980) (2)
Some aspects of opiate receptors. (1980) (2)
A766 INTRA-ARTICULAR MORPHINE PRODUCES ANALGESIA FOLLOWING ARTHROSCOPIC KNEE SURGERY (1990) (2)
[Participation of opioids and opioid receptors in antinociception at various levels of the nervous system]. (1989) (2)
Opiate Addiction – New Perspectives in Research (1979) (2)
[A comparison of the analgetic action of intravenously and intraventricularly injected morphine-like substances, taking into account their fat solubility]. (1969) (2)
Mixed type inhibition of [D-Ala2, D-Leu5]enkephalin binding to mu-opiate binding sites by mu-, but not by kappa-opiate ligands. (1982) (1)
Neuronal sensitivity and opiate tolerance/dependence. (1982) (1)
[Central and peripheral effects of cholinomimetics and their dependence on lipoid solubility]. (1966) (1)
Release of beta-endorphin from rat pituitary in vitro. (1978) (1)
Opiate suppression of luteinising hormone secretion involves central binding sites different from those mediating opiate effects on prolactin secretion (1985) (1)
Aspects of Pharmacokinetics of Opiates (1973) (1)
Evidence for a Role of Endorphins in Emotional Hyperthermia (1978) (1)
Tolerance to stimulation produced analgesia from the periaqueductal grey (PAG) of freely-moving rat and its mediation by μ-opioid receptors (1987) (1)
[Interaction between morphine and morphine antagonists following intravenous and intraventricular application]. (1969) (1)
Attenuation of the Inhibitory Action of Corticotropin-Releasing Hormone on Luteinizing Hormone Secretion After Chronic Opioid Receptor Occupation (1989) (1)
Development of selective tolerance to particular types of opiate receptors. (1982) (1)
Changes of Focal Potentials by Iontophoretic Application of Glutamic Acid and Gamma-Amino-Butyric Acid (1972) (1)
Extrahypothalamic corticotropin and alpha-melanotropin in human brain. (1980) (1)
delta EPhe4-enkephalin analogs. Delta receptors in rat brain are different from those in mouse vas deferens. (1987) (1)
Some Thoughts on the Present Status and Future of Opioid Research (1991) (1)
Enhancement of delta- but not mu-opiate agonist binding by calcium. (1982) (1)
The direction of opiodid agonists towards mu-, delta- and epsilon-receptors in the vas deferens of the mouse and the rat. (1980) (1)
Pharmacological manipulation of opiate-like peptide systems (1980) (1)
Opiate receptor binding characteristics of dimeric analogues of mu-selective DAGO-enkephalin. (1986) (1)
Recent developments in opiate research and their implications for psychiatry (1976) (1)
Endogenous Opioids and Addiction1 (1980) (1)
DEPENDENCE LIABILITY OF OPIATE-LIKE PEPTIDES (1978) (1)
[Problems in quantification of provoked morphine withdrawal in rats]. (1974) (1)
Morphine increases ACTH-secretion by activating CRF-release and sympathetic neuronal pathways (1988) (1)
Lack of barium-induced excitation in the cerebral cortex and hippocampus of morphine tolerant/dependent rats [proceedings]. (1979) (1)
Release of beta-endorphin from rat hypothalamus in vitro. (1979) (1)
Intraartikuläre Morphinapplikation zur Analgesie nach arthroskopischen Operationen am Kniegelenk (1991) (1)
Production and characterization of anti-idiotypic antiopioid receptor antibodies. (1989) (1)
On the role of striatal and nonstriatal dopamine in opiate withdrawal. (1977) (1)
Local inflammation of the rat paw enhances opioid receptor density in paw tissue and their axonal transport in sciatic nerve (1994) (1)
[The role of multiple opioid receptors and their ligands in pain modulation]. (1984) (1)
Rapid changes in enkephalin levels in rat striatum and hypothalamus induced by diazepam T. Duka, M. Wuster and A. Herz, Naunyn-Schmiedeberg's Arch. exp. Path. Pharmak., 309 (1979) 1–5 (1980) (1)
Proceedings: Site of action of morphine in the development of physical dependence in rats. (1974) (1)
[Endorphins and the occurrence of pain]. (1981) (1)
Midbrain stimulation-produced analgesia in the rat: Characterization of role of brain β-endorphin (1984) (1)
A methodology for discovering Nigella sativa, international recipes and its benefits : cooking with Nigella sativa (2012) (1)
The Role of Opioid Peptides in Placebo-induced Effects (1986) (1)
[Receptor occupation and pharmacological activity as demonstrated on opiates (author's transl)]. (1977) (1)
The neuroleptics. 2. Neurophysiology and neuropharmacology. (1970) (1)
[Opioids and the occurrence of pain]. (1986) (0)
Steroid-opioid interaction in the control of hypothalamic β-endorphin and dynorphin release in vitro (1987) (0)
Multiplicity of endogenous opioid ligands and receptors (1992) (0)
215 Relationship between anti-arecolin activity and potentiation of the pseudo-narcotic action of morphine by atropine substitutes (1961) (0)
731 – COMPARISON BETWEEN PRECIPITATED AND ABRUPT MORPHINE WITHDRAWAL (1977) (0)
Neutral Salt Reactions with reference to their Influence in the Acid Dyebath (2008) (0)
[Structure-activity correlates, using regression analysis in the series of morphine-like analgesics]. (1970) (0)
[On the dependence of central and peripheral effects of belladonna alkaloids on the presence of a hyoscyaminesterase in some rabbits]. (1963) (0)
[From the field of neuropharmacology]. (1966) (0)
[Cortical and subcortical reaction potentials after sensory stimulation in wakefull and sleeping cat]. (1966) (0)
Des-Tyr1-gamma-endorphin in schizophrenia. (1980) (0)
Selective Tolerance Development Facilitates a Differentiation of Multiple Opiate Receptors (1984) (0)
The pharmacology of synapses (1970) (0)
Antagonists with negative intrinsic activity at 6 opioid receptors (2004) (0)
Qualitative Method of Distinguishing between Wool Gelatine and Animal Size, and some Properties of Wool Gelatine. (2008) (0)
The Permutit Process of Water Softening (2008) (0)
This Week's Citation Classic®_______ the Midbrain as Site of Opioid Antinociception (0)
6 – OPIATE RECEPTORS, THEIR ENDOGENOUS LIGANDS AND CHRONIC OPIATE ACTIONS (1978) (0)
Local opioid receptors mediating antinociception in inflammation: Activation by exogenous and endogenous ligands (1990) (0)
Subject Index Vol. 47, 1988 (1988) (0)
Parmacological changes in evoked potentials in the cat, compared with changes in the waking-sleep cycle. (1969) (0)
The influence of lipid solubility upon the relation between central and peripheral activity of cholinolytic drugs (1963) (0)
[Biochemical-pharmacological aspects of opiate addiction]. (1982) (0)
[Significance of catecholamines for the manifestation of morphine withdrawal in the rat]. (1974) (0)
[Pharmacokinetics of Fentanyl after intravenous injection in rabbits and men]. (1970) (0)
Low permeation of systemically administered human beta-endorphin into rabbit brain measured by radioimmunoassays differentiating human and rabbit beta-endorphin. (1980) (0)
[-Lactose in the treatment of infantile gastrointestinal disorders]. (1951) (0)
Kappa-opiate receptors mediate psychotomimetic effects in humans (1986) (0)
Influence of Freund's adjuvant-induced inflammatory pain upon opioid peptide release in the hypothalamus (1990) (0)
Corticotropin releasing hormone effects on peptidergic neurons of the hypothalamus. (1987) (0)
BRADFORD JUNIOR BRANCH (2008) (0)
[On the modification of the central suppressing and stimulating action of morphine by anticholinergic, nicotinolytic and antihistaminic drugs in the rat]. (1961) (0)
The neuroleptics. Proceedings of the interdisciplinary week of neuroleptics (1971) (0)
LHRH response to naloxone in vitro depends upon level of testosterone replacement in vivo (1985) (0)
Subject Index Vol. 35, 1982 (1982) (0)
Chapter 2 Neurophysiology and Neuropharmacology (1970) (0)
TOLERANCE TO FENTANYL IN A MODEL THAT AVOIDS OPIOID WITHDRAWAL (1993) (0)
Endogenous opioid peptides — an update (1987) (0)
Effects of chronic inflammatory pain upon opioid peptide release in the hypothalamus (1990) (0)
International Narcotic Research Conference (14th) Held at Garmisch-Partenkirchen, West Germany on 27 June-1 July 1983. (1984) (0)
CHARACTERISTICS OF NEUROPEPTIDES (1984) (0)
A SUBCLASSIFICATION OF MULTIPLE OPIATE TOLERANCE DEVELOPMENT RECEPTORS BY IJIEANS OF SELECTIVE (1983) (0)
NONSPECIFIC ACTIONS OF OPIOIDS IN RAT HIPPOCAMPUS (1978) (0)
[Drug dependance and habituation from biochemical-pharmacological viewpoint]. (1973) (0)
[Mediator of analgesia and addiction. Control point mechanism of opiate receptors]. (1983) (0)
Clinical trial of des-tyrosyl-gamma-endorphin in mental illness. (1982) (0)
Pronase P resistant endogenous opiate-like acting materials (1979) (0)
[Autoradiographic demonstration of 14C-labelled morphine following intraventricular and intracerebral injection]. (1968) (0)
[Multiple opioid systems: theoretical aspects]. (1987) (0)
Action of [Des-Tyr1]-gamma-endorphin in schizophrenia. (1981) (0)
[Neuroendocrinological aspects of endorphins]. (1980) (0)
Neurochemical aspects of opioid addiction (1990) (0)
1442 – POSSIBLE ROLE OF CEREBROSIDE SULFATE IN OPIATE RECEPTOR MECHANISM (1978) (0)
Morphine inhibits the release of noradrenaline in the mouse vas deferens by a calcium dependent mechanism (1979) (0)
Opioids and addictive processes (1997) (0)
[Drug dependence and addiction from biochemical and pharmaceutical viewpoints]. (1974) (0)
[Fields of reaction potentials in the caudate nucleus following microelectrophoretic application of glutamic acid]. (1969) (0)
Professor Dr. Helmut CoperDecember 30, 1925–August 30, 2013 Professor for Neuropsychopharmacology, FU Berlin (1967–94) (2014) (0)
[Comparison of the development of morphine dependence and morphine tolerance in rats]. (1974) (0)
Effects of opiates and opiateantagonists on cortical neurones in naive and tolerant-dependent rats (1976) (0)
BRAIN AND PITUITARY OPIOID PEPTIDES: PHARMACOLOGICAL MANIPULATION OF CONTENT AND RELEASE (1980) (0)
In vitro demonstration that CRF inhibition of LH secretion occurs at a central site not involving opiatergic mechanisms (1986) (0)
Subject Index Vol. 33, 1981 (1981) (0)
Endogenous opioid peptides inhibit, but exogenous kappa-opioid agonists enhance the release of CRF in rats (1986) (0)
Non-specific actions of opioids in the rat hippocampus [proceedings]. (1978) (0)
[Letter: Drug abuse]. (1976) (0)
[INHIBITION OF NOCICEPTIVE AND CONDITIONED REACTIONS BY CHOLINOMIMETICS IN COMPARISON WITH THE ACTION OF OTHER CENTRALLY-ACTIVE SUBSTANCES]. (1964) (0)
VEPhe 4-enkephalin analogs Delta receptors in rat brain are different from those in mouse vas deferens (2001) (0)
[Endogenous opiates (endorphins) and pain]. (1978) (0)
Remarkable Atmospheric Action on Yarn dyed with Acid Green extra (2008) (0)
POTENTIATION OF OPIATE EFFECTS IN THE NEUROBLASTOMA CELL LINE N18TG-2 BY SULFATIDE INCORPORATION (1980) (0)

This paper list is powered by the following services:

Albert Herz's Academic­Influence.com Rankings

Albert Herz's Degrees

Why Is Albert Herz Influential?

Albert Herz's Published Works

Published Works

Albert Herz's AcademicInfluence.com Rankings